SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-20-000120
Filing Date
2020-11-05
Accepted
2020-11-05 08:29:05
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blph-20200930.htm   iXBRL 10-Q 1040009
2 EX-31.1 blph09302010qexhibit311.htm EX-31.1 8689
3 EX-31.2 blph09302010qexhibit312.htm EX-31.2 8678
4 EX-32 blph09302010qexhibit32.htm EX-32 7439
  Complete submission text file 0001600132-20-000120.txt   4724464

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20200930.xsd EX-101.SCH 32593
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20200930_cal.xml EX-101.CAL 44603
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20200930_def.xml EX-101.DEF 158742
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20200930_lab.xml EX-101.LAB 436382
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20200930_pre.xml EX-101.PRE 270263
10 EXTRACTED XBRL INSTANCE DOCUMENT blph-20200930_htm.xml XML 774687
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 201288838
SIC: 2834 Pharmaceutical Preparations